Table 1. Baseline clinical features of 93 non-Hodgkin lymphoma patients.

Characteristics

No. of patients (%)

Median age 65-74 75-90 Sex (male/female) Classifying of NHL Indolent type Follicular lymphoma MALT lymphoma Lymphoplasmacytic lymphoma Nodal marginal zone lymphoma Aggressive type Diffuse large B-cell lymphoma Angioimmunoblastic T-cell lymphoma Peripheral T-cell lymphoma NK/T-cell lymphoma Mantle cell lymphoma Anaplastic large cell lymphoma Adult T-cell leukaemia/ lymphoma Burkitt lymphoma Ann-Arbor stage I-II III-IV Performance status 0-1 2-4 Treatment Chemotherapy R-CHOP CHOP Methotrexate R-COP Others Radiation Surgery Best supportive care Treatment of doxorubicin Including doxorubicin Without doxorubicin

77 53 (57) 40 (43) 43/50 16 (17) 9 (10) 5 (5) 1 (1) 1 (1) 77 (83) 66 (71) 2 (2) 2 (2) 2 (2) 2 (2) 1 (1) 1 (1) 1 (1) 41 (44) 52 (56) 73 (78) 20 (22) 82 (88) 55 (59) 9 (10) 4 (4) 3 (3) 11 (12) 5 (5) 4 (4) 2 (2) 66 (71) 27 (29)

NHL, non-Hodgkin lymphoma; MALT, extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue type; R-CHOP, rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone; R-COP, rituximab, cyclophosphamide, vincristine, prednisolone